Evidence map›Paper›PMID 26193329›Full record

ArticleBiomolecules2015

Characterization of Receptor Binding Profiles of Influenza A Viruses Using An Ellipsometry-Based Label-Free Glycan Microarray Assay Platform.

Yiyan Fei, Yung-Shin Sun, Yanhong Li, Hai Yu, Kam Lau, James P Landry, Zeng Luo, Nicole Baumgarth, Xi Chen, Xiangdong Zhu

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. H3N2 influenza A virus gradually adapts to human-type receptor binding and entry specificity after the start of the 1968 pandemic.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Synthesis ofFrontiers in immunology · 2019
    Review
  20. ComparativeJournal of virology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Yiyan FeiKey Laboratory of Micro and Nano Photonic Structures (Ministry of Education), Department of Optical Science and Engineering, Shanghai Engineering Research Center of Ultra-Precision Optical Manufacturing, Fudan University, 220 Handan Road, Shanghai 200433, China. fyy@fudan.edu.cn.
Yung-Shin SunDepartment of Physics, University of California, Davis, CA 95616, USA. bacan1125@gmail.com.
Yanhong LiDepartment of Chemistry, University of California, Davis, CA 95616, USA. yhzli@ucdavis.edu.
Hai YuDepartment of Chemistry, University of California, Davis, CA 95616, USA. hyu@ucdavis.edu.
Kam LauDepartment of Chemistry, University of California, Davis, CA 95616, USA. edlau@ucdavis.edu.
James P LandryDepartment of Physics, University of California, Davis, CA 95616, USA. jim.landry@gmail.com.
Zeng LuoCenter for Comparative Medicine, University of California, Davis, CA 95616, USA. zluo@ucdavis.edu.
Nicole BaumgarthCenter for Comparative Medicine, University of California, Davis, CA 95616, USA. nbaumgarth@ucdavis.edu.
Xi ChenDepartment of Chemistry, University of California, Davis, CA 95616, USA. chen@chem.ucdavis.edu.
Xiangdong ZhuDepartment of Physics, University of California, Davis, CA 95616, USA. xdzhu@physics.ucdavis.edu.
University of California, Davis · USFudan University · CN

Funding

High-Speed Label-Free Optical Detection System for Small-Molecule MicroarraysR01HG003827 · NHGRI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ZHU, XIANGDONG · 2006 to 2009
$2.2M
Studies of Naturally Occurring Structurally Modified CarbohydratesR01GM076360 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHEN, XI · 2006 to 2010
$1.9M
Oligosaccharides as antimicrobials and prebioticsR01HD065122 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHEN, XI · 2010 to 2013
$1.8M
NHGRI NIH HHS R01 HG003827NHGRI NIH HHS R01HG003827NICHD NIH HHS R01 HD065122NICHD NIH HHS R01HD065122NIGMS NIH HHS R01 GM076360NIGMS NIH HHS R01GM076360-04S1
6 · The paper itself

Abstract

A key step leading to influenza viral infection is the highly specific binding of a viral spike protein, hemagglutinin (HA), with an extracellular glycan receptor of a host cell. Detailed and timely characterization of virus-receptor binding profiles may be used to evaluate and track the pandemic potential of an influenza virus strain. We demonstrate a label-free glycan microarray assay platform for acquiring influenza virus binding profiles against a wide variety of glycan receptors. By immobilizing biotinylated receptors on a streptavidin-functionalized solid surface, we measured binding curves of five influenza A virus strains with 24 glycans of diverse structures and used the apparent equilibrium dissociation constants (avidity constants, 10-100 pM) as characterizing parameters of viral receptor profiles. Furthermore by measuring binding kinetic constants of solution-phase glycans to immobilized viruses, we confirmed that the glycan-HA affinity constant is in the range of 10 mM and the reaction is enthalpy-driven.

Indexed as

Optical DevicesAnimalsHumansInfluenza A virusInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H5N1 SubtypeKineticsLigandsMicroarray AnalysisPolysaccharidesReceptors, VirusSpecies SpecificitySubstrate SpecificityThermodynamicsLigandsPolysaccharidesReceptors, Virusbinding profilebiosensorsellipsometryglycanshigh-throughputinfluenza A viruslabel-freemicroarrayreaction kinetics

Identifiers

PMID26193329
PMCPMC4598760
OpenAlexW1836834345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.